Clinical implications of postoperative carbohydrate antigen 19-9 as a serological indicator of positive resection margin and occult distant metastasis in patients with resected pancreatic cancer
Not Applicable
- Conditions
- pancreatic ductal adenocarcinoma
- Registration Number
- JPRN-UMIN000034453
- Lead Sponsor
- Tochigi Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 166
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with macroscopically positive resection margin or distant metastasis were excluded. Patients with Pre-CA 19-9 < 5 U/ml were excluded. CA 19-9 values were not included in the analysis if serum total bilirubin was >2.0 mg/dl at the time of assay.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method